Company profile: I-Flow
1.1 - Company Overview
Company description
- Provider of automated AC drain line cleaning solutions, offering the iFLO Smart Automated AC Drain Line Cleaning System that dispenses a cleaning solution based on local weather to prevent clogs and leaks, iFLO Cleaner Cartridges with a bio-enzymatic solution to break down and prevent Zooglea buildup, and the iFLO App for device setup, management, notifications, and maintenance schedules.
Products and services
- IFLO® App: Mobile software that assists initial setup and ongoing management of the iFLO device, sending notifications and maintenance schedule updates for AC drain line cleaning operations
- IFLO® Cleaner Cartridges: Bio-enzymatic refills engineered to break down and prevent Zooglea buildup in AC drain lines, supplying the iFLO system with targeted cleaning chemistry
- IFLO® Smart Automated AC Drain Line Cleaning System: Weather-responsive device that automates AC condensate drain cleaning by dispensing solution based on local conditions to prevent clogs and leaks
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to I-Flow
NeuroMetrix
HQ: United States
Website
- Description: Provider of medical devices for the detection, diagnosis, monitoring, and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome). Products include DPNCheck, a point-of-care sural nerve conduction test; Quell Fibromyalgia, a wearable neurostimulation device; and ADVANCE System, a platform to screen and confirm median nerve entrapment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroMetrix company profile →
Ivivi Technologies
HQ: United States
Website
- Description: Provider of medical technology, engaging in the design, development, and commercialization of electrotherapeutic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ivivi Technologies company profile →
Regenesis
HQ: United States
Website
- Description: Provider of medical equipment focused on non-drug pain relief solutions, manufacturing devices designed to alleviate pain without pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regenesis company profile →
CoLucid
HQ: United States
Website
- Description: Provider of biotechnology therapies targeting central nervous system disorders, developing COL-144, a neurally acting anti-migraine agent for treating migraine, and COL-204, a conjugated stigmine platform producing novel chemical entities for therapy of sleep/wake disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoLucid company profile →
Eliem Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology treatments for nervous system disorders, including ETX-155, an investigational oral neuroactive steroid GABAA receptor positive allosteric modulator for major depressive disorder and focal onset seizures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eliem Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for I-Flow
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to I-Flow
2.2 - Growth funds investing in similar companies to I-Flow
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for I-Flow
4.2 - Public trading comparable groups for I-Flow
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →